Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn’s Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn’s Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2021, Issue -, Pages 1-17
Publisher
Hindawi Limited
Online
2021-09-16
DOI
10.1155/2021/7308897
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological inhibition of GLUT1 as a new immunotherapeutic approach after myocardial infarction
- (2021) Ziyi Chen et al. BIOCHEMICAL PHARMACOLOGY
- PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis
- (2020) Dae-Seok Kim et al. GENES & DEVELOPMENT
- Insights into the functional aspects of poly(ADP‐ribose) polymerase‐1 (PARP‐1) in mitochondrial homeostasis in Dictyostelium discoideum
- (2020) Ashlesha Kadam et al. BIOLOGY OF THE CELL
- Thermodynamic efficiency, reversibility, and degree of coupling in energy conservation by the mitochondrial respiratory chain
- (2020) Mårten Wikström et al. Communications Biology
- Mitochondrial disorders of the OXPHOS system
- (2020) Erika Fernandez‐Vizarra et al. FEBS LETTERS
- Poly(ADP‑ribose) polymerase‑1 inhibitor ameliorates dextran sulfate sodium‑induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF‑κB signaling pathway
- (2020) Shuai Peng et al. Experimental and Therapeutic Medicine
- Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
- (2019) Jierui Cai et al. Gastroenterology Research and Practice
- Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease
- (2019) Danielle Carson et al. CELLULAR MICROBIOLOGY
- Anti-Inflammatory and Antioxidant Properties of Dehydrated Potato-Derived Bioactive Compounds in Intestinal Cells
- (2019) Manuela Giovanna Basilicata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
- (2019) Simonetta Pazzaglia et al. Cells
- Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth
- (2018) Caroline C. Gillis et al. Cell Host & Microbe
- Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis
- (2018) Eva Rath et al. Nature Reviews Gastroenterology & Hepatology
- Intestinal barriers protect against disease
- (2018) Sandra Citi SCIENCE
- PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome
- (2018) Antal Tapodi et al. BIOCHEMICAL PHARMACOLOGY
- Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation
- (2017) Sandra Heller et al. FASEB JOURNAL
- NAD metabolism fuels human and mouse intestinal inflammation
- (2017) Romana R Gerner et al. GUT
- Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn’s Disease
- (2017) Jue-Rong Feng et al. Gastroenterology Research and Practice
- Application of the Onodera prognostic nutrition index and neutrophil-to-lymphocyte ratio in risk evaluation of postoperative complications in Crohn’s disease
- (2017) Wei-Ming Kang et al. Scientific Reports
- The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
- (2016) L. Oplustil O'Connor et al. CANCER RESEARCH
- The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival
- (2016) T. Jubin et al. CELL PROLIFERATION
- Oxygen metabolism and barrier regulation in the intestinal mucosa
- (2016) Louise E. Glover et al. JOURNAL OF CLINICAL INVESTIGATION
- Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
- (2016) Nathan D Mathewson et al. NATURE IMMUNOLOGY
- High Concentrations of H2O2 Make Aerobic Glycolysis Energetically More Favorable for Cellular Respiration
- (2016) Hamid R. Molavian et al. Frontiers in Physiology
- Metabolic reprogramming in macrophages and dendritic cells in innate immunity
- (2015) Beth Kelly et al. CELL RESEARCH
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis
- (2014) S. A. Andrabi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial Gene Polymorphisms That Protect Mice From Colitis
- (2013) Florian Bär et al. GASTROENTEROLOGY
- Neutrophil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis
- (2013) Mehmet Celikbilek et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis
- (2012) Srikanth Santhanam et al. INFLAMMATORY BOWEL DISEASES
- Intestinal barrier function in health and gastrointestinal disease
- (2012) M. Camilleri et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Glutamine Treatment Attenuates Endoplasmic Reticulum Stress and Apoptosis in TNBS-Induced Colitis
- (2012) Irene Crespo et al. PLoS One
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon
- (2011) Dallas R. Donohoe et al. Cell Metabolism
- Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
- (2011) Warren Strober et al. GASTROENTEROLOGY
- Inflammatory Bowel Disease
- (2010) Arthur Kaser et al. Annual Review of Immunology
- Seroreactivity against glycolytic enzymes in inflammatory bowel disease
- (2010) Nathalie Vermeulen et al. INFLAMMATORY BOWEL DISEASES
- The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
- (2010) Rudolf Schicho et al. INFLAMMATORY BOWEL DISEASES
- Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohnʼs disease
- (2009) Belén Beltrán et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search